Suxamethonium Sensitivity

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Suxamethonium Sensitivity trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07550777

Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab

Bevacizumab, an anti-VEGF (vascular endothelial growth factor) agent used in the treatment of diabetic retinopathy and macular edema associated with retinal vei…

Turkey (Türkiye)180 participantsStarted 2025-11-03

Treatment: blood test

RecruitingNot Applicable

NCT06707532

The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)

The study aims to improve the safety of the electroporation ablation (PFA) procedure by using muscle relaxants to reduce skeletal muscle damage during the proce…

Poland32 participantsStarted 2024-08-01

Treatment: Propofol, Rocuronium

All recent trials (13 shown)

CompletedNot Applicable

NCT05550584

High Flow Oxygen During Operative Hysteroscopy.

High-flow nasal cannula (HFNC) oxygen therapy represents an open circuit ventilation system that uses flows up to 70 L/min of 100% oxygen through the Optiflow T…

Italy180 participantsStarted 2022-06-17

Treatment: Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE)., LMA

CompletedNot Applicable

NCT04748744

Value of Butyrylcholinesterase as a Marker of Surgical Site Infection Following Surgery for Colorectal Diseases

Butyrylcholinesterase (BChE) is an α-glycoprotein synthesized in the liver. BchE's serum level decreases in many clinical conditions such as acute and chronic l…

Greece400 participantsStarted 2019-11-06

Treatment: Butyrylcholinesterase

Suxamethonium Sensitivity

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab

The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)

All recent trials (13 shown)

High Flow Oxygen During Operative Hysteroscopy.

Value of Butyrylcholinesterase as a Marker of Surgical Site Infection Following Surgery for Colorectal Diseases

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab

The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)

All recent trials (13 shown)

High Flow Oxygen During Operative Hysteroscopy.

Value of Butyrylcholinesterase as a Marker of Surgical Site Infection Following Surgery for Colorectal Diseases

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturati…

Race-Specific Propofol Titration to Effect for Procedural Sedation

Point of Care Testing of Cholinesterase Activity During Burn- and Polytrauma

Comparison on Succinylcholine Onset Time Assessed by Train of Four Stimulation Versus Clinical Judgment During Rapid Seq…

Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance

A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease

Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects

Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles

Use of Donepezil for Treatment of Cocaine Dependence